Literature DB >> 17233560

Epitomics: global profiling of immune response to disease using protein microarrays.

Madhumita Chatterjee1, Alexei Ionan, Sorin Draghici, Michael A Tainsky.   

Abstract

The immune system retains memory of current and past infections and can sense the presence of cancer by elaborating autoantibodies to tumor proteins. In the presence of an autoimmune disease, the immune system is an efficient, natural biosensor. Therefore we exploit the immune system through a high-throughput process to isolate disease-specific epitopes for diagnostic and therapeutic purposes. These cloned disease-specific antigens are robotically spotted onto protein microarrays and interrogated with serum from the subjects under analyses. These arrays deliver personalized profiles of antigenic exposures and therapeutic targets for personalized immunotherapy. The immune system is the ultimate biosensor, superior to anything a human could create and ready to be exploited for biotechnology and biomedicine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17233560     DOI: 10.1089/omi.2006.10.499

Source DB:  PubMed          Journal:  OMICS        ISSN: 1536-2310


  8 in total

1.  Phage Microarrays for Screening of Humoral Immune Responses.

Authors:  Ana Montero-Calle; Pablo San Segundo-Acosta; María Garranzo-Asensio; Guillermo Solís-Fernández; Maricruz Sanchez-Martinez; Rodrigo Barderas
Journal:  Methods Mol Biol       Date:  2021

2.  Identification of MST1/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays.

Authors:  Ingrid Babel; Rodrigo Barderas; Ramón Diaz-Uriarte; Víctor Moreno; Adolfo Suarez; María Jesús Fernandez-Aceñero; Ramón Salazar; Gabriel Capellá; J Ignacio Casal
Journal:  Mol Cell Proteomics       Date:  2011-01-12       Impact factor: 5.911

Review 3.  Usage of cancer associated autoantibodies in the detection of disease.

Authors:  Steven P Dudas; Madhumita Chatterjee; Michael A Tainsky
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

4.  Autoantibody approach for serum-based detection of head and neck cancer.

Authors:  Ho-Sheng Lin; Harvinder S Talwar; Adi L Tarca; Alexei Ionan; Madhumita Chatterjee; Bin Ye; Jerzy Wojciechowski; Saroj Mohapatra; Marc D Basson; George H Yoo; Brian Peshek; Fulvio Lonardo; Chuan-Ju G Pan; Adam J Folbe; Sorin Draghici; Judith Abrams; Michael A Tainsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11       Impact factor: 4.254

5.  Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.

Authors:  Ingrid Babel; Rodrigo Barderas; Ramón Díaz-Uriarte; Jorge Luis Martínez-Torrecuadrada; Marta Sánchez-Carbayo; J Ignacio Casal
Journal:  Mol Cell Proteomics       Date:  2009-07-28       Impact factor: 5.911

6.  Protein Microarrays for Ocular Diseases.

Authors:  Guillermo Solís-Fernández; Ana Montero-Calle; Miren Alonso-Navarro; Miguel Ángel Fernandez-Torres; Victoria Eugenia Lledó; María Garranzo-Asensio; Rodrigo Barderas; Ana Guzman-Aranguez
Journal:  Methods Mol Biol       Date:  2021

7.  Serum prognostic biomarkers in head and neck cancer patients.

Authors:  Ho-Sheng Lin; Fauzia Siddiq; Harvinder S Talwar; Wei Chen; Calin Voichita; Sorin Draghici; Gerald Jeyapalan; Madhumita Chatterjee; Andrew Fribley; George H Yoo; Seema Sethi; Harold Kim; Ammar Sukari; Adam J Folbe; Michael A Tainsky
Journal:  Laryngoscope       Date:  2014-01-29       Impact factor: 3.325

Review 8.  DNA repair of oxidative DNA damage in human carcinogenesis: potential application for cancer risk assessment and prevention.

Authors:  Tamar Paz-Elizur; Ziv Sevilya; Yael Leitner-Dagan; Dalia Elinger; Laila C Roisman; Zvi Livneh
Journal:  Cancer Lett       Date:  2008-04-18       Impact factor: 8.679

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.